NCT00633776View on ClinicalTrials.gov

Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Chronic Obstructive Pulmonary DiseaseCOPDChronic BronchitisEmphysema
Interventions
DRUG

formoterol fumarate

Nebulized formoterol fumarate 20 mcg one-time treatment; aerosolizer dry powder formoterol fumarate 12 mcg one-time treatment

Trial Locations (1)

90095

UCLA David Geffen School of Medicine, Los Angeles

Sponsors

Collaborators (1)

Dey, L.P.
All Listed Sponsors
collaborator

Dey, L.P.

UNKNOWN

lead

University of California, Los Angeles

OTHER